Stroke management Flashcards
Stroke causes
85% ischemic (20% large artery atherosclerosis 25% small vessel lacunar stroke 20% cardioembolism 30% cryptogenic 5% others)
15% hemorrhagic
Ischemic stroke mechanisms
intracranial atherosclerosis small artery disease carotid plaque with emboli carotid stenosis aortic arch plaque a fib valve disease ventricular thrombi cardiogenic emboli
Cardioembolic sources
atrial septal aneurysm patent foramen ovale a fib mitral stenosis mechanical vegetation cardiomyopathy MI
A fib and stroke
1% of population in NA and europe AF
5% of those over 65
2.5 mil Americans
1 of every 6 strokes due to AF
CHADS2
1 point: CHF Hypertension Age > 75 Diabetes
2 points:
stroke, TIA
ACA stroke symptoms
Leg > arm weakness
Leg > arm numbness
Abulia
MCA stroke symptoms
Hemiplegia --> affect motor strip Cortical features: - aphasia - neglect - visual field deficit - gaze deviation
Posterior circulation stroke symptoms
brainstem --> more nucleus/tract defects Visual field defects vertigo Diplopia Ataxia Dysphagia Weakness Numbness
Small vessel disease lacunar stroke syndrome
pure motor pure sensory mixed sensorimotor dysarthria - clumsy ataxia hemiparesis
Hyperacute/acute stroke treatment
iv-tPA endovascular mechanical thrombectomy aspirin stroke unit hemicranectomy
Secondary stroke prevention
antiplatelets (aspirin, clopidogrel, ASA and dipyridimole) anticoagulants (warfarin, NOACs) carotid revascularization (carotid endarterectomy, carotid stent)
Tissue plasminogen activator
serine protease
converts plasminogen –> plasmin
fibrinolytic
only effective FDA approved treatment for acute ischemic stroke
10% bolus then infusion over 1 hour within 3 hours of symptom onset
Antiplatelets for 2ndary stroke prevention (non-cardioembolic)
Aspirin Clopidogrel slightly better than ASA ASA + DP superior to ASA Clopidogrel + ASA NOT indicated ASA + DP NOT superior to clopidogrel Do not combine anticoagulants + antiplatelets!! Start tx as soon as possible long-term treatment
Hypertension control for stroke prevention
absolute target uncertain
benefits associated with overall reduction of 10/5 mmHg
optimal drug regimen uncertain - diuretic + ACEi?
European guidelines for management of hypertension
General:
TIA
episode of neurological deficit where symptoms resolve fully, noe vidence of loss of blood flow